Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Tax Provisions (2023)

Contineum Therapeutics has reported Tax Provisions over the past 1 years, most recently at -$150000.0 for Q4 2023.

  • Quarterly results put Tax Provisions at -$150000.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Sep 2024 was -$150000.0 (changed N/A YoY), and the annual figure for FY2023 was $450000.0, changed.
  • Tax Provisions for Q4 2023 was -$150000.0 at Contineum Therapeutics, down from -$118000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for CTNM hit a ceiling of $729000.0 in Q2 2023 and a floor of -$150000.0 in Q4 2023.